首页|RNA N6-methyladenosine modification in cancers: current status and perspectives

RNA N6-methyladenosine modification in cancers: current status and perspectives

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据

Xiaolan Deng、Rui Su、Hengyou Weng、Huilin Huang、Zejuan Li、Jianjun Chen

展开 >

Department of Systems Biology & the Gehr Family Center for Leukemia Research, The Beckman Research Institute of City of Hope, Monrovia, CA 91016, USA

School of Pharmacy, China Medical University, Shenyang 110122, China

Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45219, USA

Department of Human Genetics, University of Chicago, Chicago, IL 60637, USA

展开 >

This work was supported in part by a grantNational Nature Science Foundation of China, as well as the National Institutes of Health (NIH) R01National Nature Science Foundation of China, as well as the National Institutes of Health (NIH) R01National Nature Science Foundation of China, as well as the National Institutes of Health (NIH) R01supported by an American Cancer Society (ACS) Research Scholar Award. J.C. is a Leukemia & Lymphoma Society (LLS) Scholar

81603149CA214965CA211614 CA178454

2018

细胞研究(英文版)
中国科学院上海生化细胞所

细胞研究(英文版)

CSTPCDCSCDSCI
影响因子：1.355
ISSN：
年,卷(期)：2018.28(5)
  • 44
  • 2